Who invested in Junhemeng Biopharmaceutical?
Junhemeng Biopharmaceutical's investors include Oriza Holdings and 3E Bioventures.
One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$1.4Mraised across 1 round since 2025, from 1 source
Junhemeng Biopharmaceutical's investors include Oriza Holdings and 3E Bioventures.
Junhemeng Biopharmaceutical has raised $1.4M across 1 round since 2025.
Junhemeng Biopharmaceutical's most recent round was a Venture of $1.4M in May 2025.
Its most recent round, $1.4M in May 2025, is also its largest on record.
Junhemeng Biopharmaceutical's first round on record, in May 2025, was backed by Oriza Holdings and 3E Bioventures.
Junhemeng Biopharmaceutical's latest named round is a Venture, in May 2025.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.